AMY PRUDEN: Open Payments
NPI 1164771473 · GONZALES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$774 in 40 payments from 14 companies in 2025. Trend: 2023 $905 · 2024 $861 · 2025 $774
Food & beverage: $774
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $130 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $90 |
| Axsome Therapeutics, Inc. | 5 | $90 |
| ABBVIE INC. | 4 | $85 |
| AstraZeneca Pharmaceuticals LP | 4 | $77 |
| Lilly USA, LLC | 3 | $58 |
| Abbott Laboratories | 2 | $51 |
| Vanda Pharmaceuticals Inc. | 2 | $39 |
| Phathom Pharmaceuticals, Inc. | 2 | $37 |
| Merck Sharp & Dohme LLC | 2 | $35 |
Products named: CAPLYTA, Auvelity, VRAYLAR, Rybelsus, JARDIANCE, FREESTYLE LIBRE 3, AIRSUPRA, FANAPT.
Industry payments across LA — which companies pay providers there.
